REFERENCES
- Wolf M, Thadhani R. Beyond minerals and parathyroid hormone: Role of active vitamin D in end-stage renal disease. Semin Dial. 2005;18:302–306.
- Lim WH, Coates PS, Russ GR, Coates PT. Hyperparathyroidism and vitamin D deficiency predispose to bone loss in renal transplant recipients. Transplantation. 2009;88:678–683.
- Courbebaisse M, Souberbielle JC, Thervet E. Potential nonclassical effects of vitamin D in transplant recipients. Transplantation. 2010;89:131–137.
- Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–281.
- Stavroulopoulos A, Cassidy MJ, Porter CJ, Hosking DJ, Roe SD. Vitamin D status in renal transplant recipients. Am J Transplant. 2007;7:2546–2552.
- Tripathi SS, Gibney EM, Gehr TW, King AL, Beckman MJ. High prevalence of vitamin D deficiency in African American kidney transplant recipients. Transplantation. 2008;85:767–770.
- Ginde AA, Liu MC, Camargo Jr CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch Intern Med. 2009;169:626–632.
- Chan R, Chan D, Woo J, . Serum 25-hydroxyvitamin D and parathyroid hormone levels in relation to blood pressure in a cross-sectional study in older Chinese men. J Hum Hypertens. 2012;26:20–27.
- Wat WZ, Leung JY, Tam S, Kung AW. Prevalence and impact of vitamin D insufficiency in southern Chinese adults. Ann Nutr Metab. 2007;51:59–64.
- Evenepoel P, Naesens M, Claes K, Kuypers D, Tertiary VY. ‘Hyperphosphatoninism’ accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients. Am J Transplant. 2007;7:1193–1200.
- Scragg R, Sowers M, Serum BC. 25-Hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004;27:2813–2818.
- Lemire JM, Archer DC, Khulkarni A, Ince A, Uskokovic MR, Stepkowski S. Prolongation of the survival of murine cardiac allografts by the vitamin D3 analogue 1,25-dihydroxy-delta 16-cholecalciferol. Transplantation. 1992;54:762–763.
- Zhang AB, Zheng SS, Jia CK, Wang Y. Effect of 1,25-dihydroxyvitamin D3 on preventing allograft from acute rejection following rat orthotopic liver transplantation. World J Gastroenterol. 2003;9:1067–1071.
- Tanaci N, Karakose H, Guvener N, Tutuncu NB, Colak T, Haberal M. Influence of 1,25-dihydroxyvitamin D3 as an immunomodulator in renal transplant recipients: A retrospective cohort study. Transplant Proc. 2003;35:2885–2887.
- Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol. 1980;9:227–231.
- Ducloux D, Courivaud C, Bamoulid J, Kazory A, Dumoulin G, Chalopin JM. Pretransplant serum vitamin D levels and risk of cancer after renal transplantation. Transplantation. 2008;85:1755–1759.
- Scragg R, Jackson R, Holdaway IM, Lim T, Beaglehole R. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: A community-based study. Int J Epidemiol. 1990;19:559–563.
- Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-Hydroxyvitamin D and risk of myocardial infarction in men: A prospective study. Arch Intern Med. 2008;168:1174–1180.
- de Boer IH, Kestenbaum B, Shoben AB, Michos ED, Sarnak MJ, Siscovick DS. 25-Hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol. 2009;20:1805–1812.
- Artaza JN, Mehrotra R, Norris KC. Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol. 2009;4:1515–1522.
- Cozzolino M, Ketteler M, Zehnder D. The vitamin D system: A crosstalk between the heart and kidney. Eur J Heart Fail. 2010;12:1031–1041.